These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 21071684)
1. Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants. El-Khuffash AF; Slevin M; McNamara PJ; Molloy EJ Arch Dis Child Fetal Neonatal Ed; 2011 Mar; 96(2):F133-7. PubMed ID: 21071684 [TBL] [Abstract][Full Text] [Related]
2. Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage. El-Khuffash A; Barry D; Walsh K; Davis PG; Molloy EJ Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F407-12. PubMed ID: 18285375 [TBL] [Abstract][Full Text] [Related]
3. Cardiac troponin T and N-terminal-pro-B type natriuretic peptide reflect myocardial function in preterm infants. El-Khuffash A; Davis PG; Walsh K; Molloy EJ J Perinatol; 2008 Jul; 28(7):482-6. PubMed ID: 18322550 [TBL] [Abstract][Full Text] [Related]
4. Plasma biomarkers and echocardiographic indices of left ventricular function in very low birth weight infants. Perugu S; Rehan VK; Chow SL; Baylen B J Neonatal Perinatal Med; 2014 Jan; 7(3):213-22. PubMed ID: 25322997 [TBL] [Abstract][Full Text] [Related]
5. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus. Letzner J; Berger F; Schwabe S; Benzing J; Morgenthaler NG; Bucher HU; Bührer C; Arlettaz R; Wellmann S Neonatology; 2012; 101(2):116-24. PubMed ID: 21952518 [TBL] [Abstract][Full Text] [Related]
6. B-type and N-terminal pro-B-type natriuretic peptides are equally useful in assessing patent ductus arteriosus in very preterm infants. König K; Guy KJ; Drew SM; Barfield CP Acta Paediatr; 2015 Apr; 104(4):e139-42. PubMed ID: 25488470 [TBL] [Abstract][Full Text] [Related]
7. Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus. Harris SL; More K; Dixon B; Troughton R; Pemberton C; Horwood J; Ellis N; Austin N Eur J Pediatr; 2018 Apr; 177(4):521-532. PubMed ID: 29352349 [TBL] [Abstract][Full Text] [Related]
8. Influence of a patent ductus arteriosus on cardiac troponin T levels in preterm infants. El-Khuffash AF; Molloy EJ J Pediatr; 2008 Sep; 153(3):350-3. PubMed ID: 18534211 [TBL] [Abstract][Full Text] [Related]
9. Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants. Ramakrishnan S; Heung YM; Round J; Morris TP; Collinson P; Williams AF Acta Paediatr; 2009 Aug; 98(8):1254-9. PubMed ID: 19432837 [TBL] [Abstract][Full Text] [Related]
10. Serial N-terminal pro-brain natriuretic peptide measurement as a predictor of significant patent ductus arteriosus in preterm infants beyond the first week of life. Letshwiti JB; Sirc J; O'Kelly R; Miletin J Eur J Pediatr; 2014 Nov; 173(11):1491-6. PubMed ID: 24898778 [TBL] [Abstract][Full Text] [Related]
11. Correlation analysis between echocardiographic flow pattern and N-terminal-pro-brain natriuretic peptide for early targeted treatment of patent ductus arteriosus. Occhipinti F; De Carolis MP; De Rosa G; Bersani I; Lacerenza S; Cota F; Rubortone SA; Romagnoli C J Matern Fetal Neonatal Med; 2014 Nov; 27(17):1800-4. PubMed ID: 24397409 [TBL] [Abstract][Full Text] [Related]
12. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Choi BM; Lee KH; Eun BL; Yoo KH; Hong YS; Son CS; Lee JW Pediatrics; 2005 Mar; 115(3):e255-61. PubMed ID: 15687418 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular biomarkers pro-atrial natriuretic peptide and pro-endothelin-1 to monitor ductus arteriosus evolution in very preterm infants. Grass B; Baumann P; Arlettaz R; Fouzas S; Meyer P; Spanaus K; Wellmann S Early Hum Dev; 2014 Jun; 90(6):293-8. PubMed ID: 24661445 [TBL] [Abstract][Full Text] [Related]
14. Can early B-type natriuretic peptide assays predict symptomatic patent ductus arteriosus in extremely low birth weight infants? Lee JH; Shin JH; Park KH; Rhie YJ; Park MS; Choi BM Neonatology; 2013; 103(2):118-22. PubMed ID: 23182972 [TBL] [Abstract][Full Text] [Related]
15. Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Puddy VF; Amirmansour C; Williams AF; Singer DR Clin Sci (Lond); 2002 Jul; 103(1):75-7. PubMed ID: 12095406 [TBL] [Abstract][Full Text] [Related]
17. [Value of amino-terminal pro-brain natriuretic peptide as a predictive marker of symptomatic patent ductus arteriosus in preterm infants]. Lu KS; Guo XL; Lv JF; Huang SL; Yang CH; Zou ZH; Chen ZJ; Lai CH; Yang BY Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1160-4. PubMed ID: 26575871 [TBL] [Abstract][Full Text] [Related]
18. Point-of-care testing for B-type natriuretic peptide in premature neonates with patent ductus arteriosus. Kalra VK; DeBari VA; Zauk A; Kataria P; Myridakis D; Kiblawi F Ann Clin Lab Sci; 2011; 41(2):131-7. PubMed ID: 21844570 [TBL] [Abstract][Full Text] [Related]
19. N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants. Nuntnarumit P; Khositseth A; Thanomsingh P J Perinatol; 2009 Feb; 29(2):137-42. PubMed ID: 19020527 [TBL] [Abstract][Full Text] [Related]
20. Effect of patent ductus arteriosus and indomethacin treatment on serum cardiac troponin T levels in preterm infants with respiratory distress syndrome. Trevisanuto D; Zaninotto M; Lachin M; Altinier S; Plebani M; Ferrarese P; Zanardo V Eur J Pediatr; 2000 Apr; 159(4):273-6. PubMed ID: 10789933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]